62 related articles for article (PubMed ID: 1831868)
1. [A case of sarcoidosis with increased CD3+ WT31- CD16+ lymphocytes].
Yoshida T; Okabe H; Ochi Y; Hosoda T; Fujiyama Y; Hosoda S
Rinsho Byori; 1991 Jun; 39(6):675-7. PubMed ID: 1831868
[TBL] [Abstract][Full Text] [Related]
2. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
Mansour I; Doinel C; Rouger P
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
[TBL] [Abstract][Full Text] [Related]
3. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
Hori T; Spits H
J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
[TBL] [Abstract][Full Text] [Related]
4. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
[TBL] [Abstract][Full Text] [Related]
5. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
6. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes.
Inverardi L; Samaja M; Motterlini R; Mangili F; Bender JR; Pardi R
J Immunol; 1992 Aug; 149(4):1416-23. PubMed ID: 1386865
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorder of granular lymphocytes. More questions than answers.
McKenna RW
Arch Pathol Lab Med; 1992 Mar; 116(3):235-7. PubMed ID: 1371378
[No Abstract] [Full Text] [Related]
8. CD3 negative "small agranular lymphocytes" are natural killer cells.
Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
[TBL] [Abstract][Full Text] [Related]
9. NK, K/ADCC and LDCC differentiation.
Moltó L; Jiménez MC; Sala ML; Guardiola M; Merino J; Campos A
Thymus; 1990 Mar; 15(2):125-8. PubMed ID: 2139752
[No Abstract] [Full Text] [Related]
10. Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors.
Khayat D; Soubrane C; Andrieu JM; Visonneau S; Eme D; Tourani JM; Beldjord K; Weil M; Fernandez E; Jacquillat C
J Infect Dis; 1990 Mar; 161(3):430-5. PubMed ID: 2138203
[TBL] [Abstract][Full Text] [Related]
11. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
[TBL] [Abstract][Full Text] [Related]
13. Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
Gorai I; Yanagibashi T; Minaguchi H
Gynecol Oncol; 1992 Feb; 44(2):137-46. PubMed ID: 1371977
[TBL] [Abstract][Full Text] [Related]
14. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
[TBL] [Abstract][Full Text] [Related]
15. Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.
Ellis TM; Creekmore SP; McMannis JD; Braun DP; Harris JA; Fisher RI
Cancer Res; 1988 Nov; 48(22):6597-602. PubMed ID: 2902918
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells and lymphocyte subsets in active MS and acute inflammation of the CNS.
Merelli E; Sola P; Faglioni P; Giordani S; Mussini D; Montagnani G
Acta Neurol Scand; 1991 Aug; 84(2):127-31. PubMed ID: 1835239
[TBL] [Abstract][Full Text] [Related]
17. CD16+ and CD56+ cells as markers of necrotizing and crescentic glomerulonephritis and active IgA glomerulonephropathy.
Hotta O; Seki S; Taguma Y; Shimoda A; Abo T; Takahashi H
Nephron; 1991; 57(2):239-40. PubMed ID: 1708443
[No Abstract] [Full Text] [Related]
18. [CD3-, OKM1+, Leu7-, Leu11+ large granular lymphocyte leukemia with ascites and CNS involvement].
Fujii H; Maekawa T; Kanoh T; Ohno T; Arita H; Taniwaki M; Urata Y
Rinsho Ketsueki; 1989 Apr; 30(4):477-84. PubMed ID: 2475653
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
Uciechowski P; Gessner JE; Schindler R; Schmidt RE
Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
[TBL] [Abstract][Full Text] [Related]
20. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
